PQIA Stock Chart & Stats
€52.84
€1.12(2.17%)
At close: 4:00 PM EDT
€52.84
€1.12(2.17%)
Day’s Range― - ―
52-Week Range€43.85 - €74.00
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€4.35B
Enterprise Value€6.06K
Total Cash (Recent Filing)€455.34M
Total Debt (Recent Filing)€1.93B
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Aug 10, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding78,634,240
10 Day Avg. Volume12
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)4.92
Price to Sales (P/S)2.63
P/FCF Ratio62.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€72.40Price Target Upside37.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.45
Revenue Forecast (FY)€2.17B
Bulls Say, Bears Say
Bulls Say
AI Platform EfficiencyDeepHealth's digital platform supports AI models that can shorten MRI scan times and increase scans per machine, boosting facility capacity and improving operating margins.
Market PositioningShift of imaging from hospitals to lower-cost outpatient centers, combined with a large multi-state RadNet network, positions the company to capture increasing scan volume and offer faster, more cost-efficient services than hospital competitors.
New Revenue StreamAI-enabled mammography has led to detection of many breast cancers and is attracting out-of-pocket payments and some payor reimbursements, creating a growing revenue stream beyond traditional imaging fees.
Bears Say
Limited New InformationAnalyst notes the report largely reiterates already disclosed information, which may limit positive market reaction due to lack of fresh catalysts.
Stock-based CompensationElevated stock-based compensation tied to development of the DeepHealth business increases reported expenses and could pressure profitability and per-share metrics until compensation levels normalize.
Radnet News
PQIA FAQ
What was Radnet’s price range in the past 12 months?
Radnet lowest stock price was €43.85 and its highest was €74.00 in the past 12 months.
What is Radnet’s market cap?
Radnet’s market cap is €4.35B.
When is Radnet’s upcoming earnings report date?
Radnet’s upcoming earnings report date is Aug 10, 2026 which is in 5 days.
How were Radnet’s earnings last quarter?
Radnet released its earnings results on May 10, 2026. The company reported -€0.243 earnings per share for the quarter, missing the consensus estimate of -€0.142 by -€0.101.
Is Radnet overvalued?
According to Wall Street analysts Radnet’s price is currently Undervalued.
Does Radnet pay dividends?
Radnet does not currently pay dividends.
What is Radnet’s EPS estimate?
Radnet’s EPS estimate is 0.16.
How many shares outstanding does Radnet have?
Radnet has 78,634,240 shares outstanding.
What happened to Radnet’s price movement after its last earnings report?
Radnet reported an EPS of -€0.243 in its last earnings report, missing expectations of -€0.142. Following the earnings report the stock price went down -4.959%.
Which hedge fund is a major shareholder of Radnet?
Currently, no hedge funds are holding shares in DE:PQIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Radnet Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€72.40 (37.01% Upside)
€72.40 (37.01% Upside)
Blogger Sentiment
Bullish
DE:PQIA Sentiment 100%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth €2.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.96%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
16.46%
Trailing 12-Months
Company Description
Radnet
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
PQIA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum and financial results: record Q1 revenue and adjusted EBITDA, meaningful advanced-imaging growth, rapid ARR expansion and a robust sales pipeline in Digital Health, strategic acquisitions and healthy liquidity. Headwinds include weather-related Q1 impacts, short-term margin dilution in Digital Health from acquisitions and investments, seasonal first-quarter expense headwinds, and ongoing payer/reimbursement work for AI monetization. Overall, management raised imaging guidance, reaffirmed Digital Health guidance, and emphasized tangible productivity gains from AI deployments, indicating confidence in durable growth despite near-term investment-driven margin pressure.View all DE:PQIA earnings summariesPQIA Stock 12 Month Forecast
Average Price Target
€72.40
▲(37.01% Upside)